Chemokine Receptor CCR1 Regulates Inflammatory Cell Infiltration after Renal Ischemia-Reperfusion Injury1

Neutrophils and macrophages rapidly infiltrate the kidney after renal ischemia-reperfusion injury, however specific molecular recruitment mechanisms have not been fully delineated for these cell types. Here we provide genetic and pharmacologic evidence supporting a positive role for the chemokine receptor CCR1 in macrophage and neutrophil infiltration in a 7 day mouse model of renal ischemia-reperfusion injury. By day 7, injured kidneys from mice lacking CCR1 contained 35% fewer neutrophils and 45% fewer macrophages than injured kidneys from wild-type control mice. Pretreatment of wild-type mice with the specific CCR1 antagonist BX471 also suppressed neutrophil and macrophage infiltration in the model. Injured kidneys from mice lacking CCR1 also had reduced content of the CCR1 ligands CCL3 (MIP-1α) and CCL5 (RANTES) compared with injured kidneys from wild-type controls, suggesting a leukocyte source for these inflammatory chemokines and existence of a CCR1-dependent positive feedback loop for leukocyte infiltration in the model. Local leukocyte proliferation and apoptosis were detected after injury, but were not dependent on CCR1. Also, the extent of necrotic and fibrotic damage and decline in renal function in injured kidneys was similar in wild-type and CCR1-deficient mice. Thus, CCR1 appears to regulate trafficking of macrophages and neutrophils to kidney in a mouse model of renal ischemia-reperfusion injury, however this activity does not appear to affect tissue injury.

[1]  S. Chadban,et al.  TLR4 activation mediates kidney ischemia/reperfusion injury. , 2007, The Journal of clinical investigation.

[2]  V. Engelhard,et al.  NKT Cell Activation Mediates Neutrophil IFN-γ Production and Renal Ischemia-Reperfusion Injury1 , 2007, The Journal of Immunology.

[3]  N. Mackman,et al.  Tissue factor deficiency and PAR-1 deficiency are protective against renal ischemia reperfusion injury. , 2007, Blood.

[4]  Hyoung-Kyu kim,et al.  Macrophages contribute to the initiation of ischaemic acute renal failure in rats. , 2006, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[5]  C. Hogaboam,et al.  MIP‐1α[CCL3] acting on the CCR1 receptor mediates neutrophil migration in immune inflammation via sequential release of TNF‐α and LTB4 , 2005 .

[6]  G. Haines,et al.  Amelioration of rat adjuvant-induced arthritis by Met-RANTES. , 2005, Arthritis and rheumatism.

[7]  H. Rabb,et al.  Effects of Combined T‐ and B‐Cell Deficiency on Murine Ischemia Reperfusion Injury , 2005, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[8]  M. Kretzler,et al.  Delayed chemokine receptor 1 blockade prolongs survival in collagen 4A3-deficient mice with Alport disease. , 2005, Journal of the American Society of Nephrology : JASN.

[9]  Liping Huang,et al.  Renal ischemia-reperfusion injury and adenosine 2A receptor-mediated tissue protection: role of macrophages. , 2005, American journal of physiology. Renal physiology.

[10]  L. Qun,et al.  Selectively frequent expression of CXCR5 enhances resistance to apoptosis in CD8+CD34+ T cells from patients with T-cell-lineage acute lymphocytic leukemia , 2005, Oncogene.

[11]  M. Kretzler,et al.  CCR1 blockade reduces interstitial inflammation and fibrosis in mice with glomerulosclerosis and nephrotic syndrome. , 2004, Kidney international.

[12]  H. Sasaki,et al.  MIP-1γ Promotes Receptor Activator of NF-κB Ligand-Induced Osteoclast Formation and Survival1 , 2004, The Journal of Immunology.

[13]  J. Friedewald,et al.  Inflammatory cells in ischemic acute renal failure. , 2004, Kidney international.

[14]  C. Alpers,et al.  Late onset of treatment with a chemokine receptor CCR1 antagonist prevents progression of lupus nephritis in MRL-Fas(lpr) mice. , 2004, Journal of the American Society of Nephrology : JASN.

[15]  C. Alpers,et al.  J Am Soc Nephrol 15: 337–347, 2004 Chemokine Receptor CCR1 But Not CCR5 Mediates Leukocyte Recruitment and Subsequent Renal Fibrosis after Unilateral Ureteral , 2022 .

[16]  R. Atkins,et al.  Macrophages in mouse type 2 diabetic nephropathy: correlation with diabetic state and progressive renal injury. , 2004, Kidney international.

[17]  Darrell R. Abernethy,et al.  International Union of Pharmacology: Approaches to the Nomenclature of Voltage-Gated Ion Channels , 2003, Pharmacological Reviews.

[18]  K. Matsushima,et al.  J Am Soc Nephrol 14: 2503–2515, 2003 CCR2 Signaling Contributes to Ischemia-Reperfusion Injury , 2022 .

[19]  K. Matsushima,et al.  Gene therapy expressing amino-terminal truncated monocyte chemoattractant protein-1 prevents renal ischemia-reperfusion injury. , 2003, Journal of the American Society of Nephrology : JASN.

[20]  M. D. de Broe,et al.  Reduced postischemic macrophage infiltration and interstitial fibrosis in osteopontin knockout mice. , 2003, Kidney international.

[21]  C. Edelstein,et al.  Neutrophil-independent mechanisms of caspase-1- and IL-18-mediated ischemic acute tubular necrosis in mice. , 2002, The Journal of clinical investigation.

[22]  P. Murphy International Union of Pharmacology. XXX. Update on Chemokine Receptor Nomenclature , 2002, Pharmacological Reviews.

[23]  C. Cohen,et al.  Roles of SLC/CCL21 and CCR7 in Human Kidney for Mesangial Proliferation, Migration, Apoptosis, and Tissue Homeostasis1 , 2002, The Journal of Immunology.

[24]  R. Star,et al.  alpha-Melanocyte-simulating hormone and interleukin-10 do not protect the kidney against mercuric chloride-induced injury. , 2002, American journal of physiology. Renal physiology.

[25]  D. W. Desmond Cognition and White Matter Lesions , 2002, Cerebrovascular Diseases.

[26]  J. Alexander,et al.  Injury in renal ischemia-reperfusion is independent from immunoglobulins and T lymphocytes. , 2002, American journal of physiology. Renal physiology.

[27]  佐藤 和一 Midkine is involved in neutrophil infiltration into the tubulointerstitium in ischemic renal injury , 2002 .

[28]  M. Salvadori,et al.  IP-10 and Mig production by glomerular cells in human proliferative glomerulonephritis and regulation by nitric oxide. , 2002, Journal of the American Society of Nephrology : JASN.

[29]  Claudio Ronco,et al.  Blood and dialysate flow distributions in hollow-fiber hemodialyzers analyzed by computerized helical scanning technique. , 2002, Journal of the American Society of Nephrology : JASN.

[30]  C. Cohen,et al.  A chemokine receptor CCR-1 antagonist reduces renal fibrosis after unilateral ureter ligation. , 2002, The Journal of clinical investigation.

[31]  ZiadMallat,et al.  Inhibition of Transforming Growth Factor-β Signaling Accelerates Atherosclerosis and Induces an Unstable Plaque Phenotype in Mice , 2001 .

[32]  A. Tedgui,et al.  Inhibition of Transforming Growth Factor- Signaling Accelerates Atherosclerosis and Induces an Unstable Plaque Phenotype in Mice , 2001 .

[33]  F. Santos,et al.  Exacerbated inflammatory response induced by insulin-like growth factor I treatment in rats with ischemic acute renal failure. , 2001, Journal of the American Society of Nephrology : JASN.

[34]  M. D. de Broe,et al.  Identification and kinetics of leukocytes after severe ischaemia/reperfusion renal injury. , 2000, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[35]  K. Matsushima,et al.  Distinct Expression of CCR1 and CCR5 in Glomerular and Interstitial Lesions of Human Glomerular Diseases , 2000, American Journal of Nephrology.

[36]  K. Ley,et al.  Blocking P‐selectin protects from ischemia/reperfusion‐induced acute renal failure , 2000, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[37]  S. Segerer,et al.  Chemokines, chemokine receptors, and renal disease: from basic science to pathophysiologic and therapeutic studies. , 2000, Journal of the American Society of Nephrology : JASN.

[38]  M. D. de Broe,et al.  Neutrophils and acute ischemia-reperfusion injury. , 1998, Journal of nephrology.

[39]  H. Broxmeyer,et al.  Impaired Host Defense, Hematopoiesis, Granulomatous Inflammation and Type 1–Type 2 Cytokine Balance in Mice Lacking CC Chemokine Receptor 1 , 1997, The Journal of experimental medicine.

[40]  C. Alpers,et al.  An evaluation of the neutrophil as a mediator of in vivo renal ischemic-reperfusion injury. , 1989, The American journal of pathology.

[41]  M. Paller Effect of neutrophil depletion on ischemic renal injury in the rat. , 1989, The Journal of laboratory and clinical medicine.